Catalog No: A10GD-4297
Cas No: 63503-05-9
Properties: Mol Formula: C16H18O5, Mol Weight: 290.31
IUPAC Name: (2S,3S,4R,5S,6S)-2-methyl-6-naphthalen-2-yloxyoxane-3,4,5-triol
Synonym: 2-Naphthyl alpha-L-fucopyranoside, 2-NAPHTHYL-ALPHA-L-FUCOPYRANOSIDE, 2-Naphthyl 6-deoxy-alpha-L-galactopyranoside
10 in stock
Catalog No: A10GD-5357
19949-47-4 , Neohesperidose heptaacetate, CAS:19949-47-4
C26H36O17 / 620.57
MFCD00017494
10 in stock
| Glycan Type | N |
| Components | “GlcNAc: 5, Man: 3, Neu5Ac: 1, Gal: 1, Fuc: 1” |
| Composition | “Neu5Ac: 1, Hex: 4, HexNAc: 5, dHex: 1” |
| Motifs | core fucose, bisectingGlcNAc, Internal LacNAc type2, Trimannosylcore |
| Termini | Neu5Ac(a2-3), GlcNAc(b1-2), Fuc(a1-6), GlcNAc(b1-4) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 9, Gal: 7, Man: 3, Neu5Ac: 1, Fuc: 1” |
| Composition | “on” |
| Motifs | Terminal LacNAc type2, core fucose, PolyLacNAc, Trimannosylcore, Chitobiose, Internal LacNAc type2 |
| Termini | Neu5Ac(a2-3), Gal(b1-4), Fuc(a1-6) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Man: 3, Neu5Ac: 1” |
| Composition | “on” |
| Motifs | Nglycan complex, Terminal LacNAc type2, Internal LacNAc type2, Trimannosylcore |
| Termini | Neu5Ac(a2-3), Gal(b1-4) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Man: 3, Neu5Ac: 1, Fuc: 1” |
| Composition | “on” |
| Motifs | Terminal LacNAc type2, Nglycan complex, Trimannosylcore, Chitobiose, Internal LacNAc type2 |
| Termini | Neu5Ac(a2-3), Gal(b1-4), Fuc(a1-3) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Man: 3, Neu5Ac: 1, Fuc: 1” |
| Composition | “on” |
| Motifs | Terminal LacNAc type2, Nglycan complex, Trimannosylcore, Chitobiose, Internal LacNAc type2 |
| Termini | Neu5Ac(a2-3), Gal(b1-4), Fuc(a1-3) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Neu5Ac: 3, Gal: 3, Man: 3, Fuc: 1” |
| Composition | “on” |
| Motifs | Chitobiose, Nglycan complex, Internal LacNAc type2, Trimannosylcore |
| Termini | Neu5Ac(a2-3), Neu5Ac(a2-6), Fuc(a1-3) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Man: 3, Neu5Ac: 1, Fuc: 1” |
| Composition | “on” |
| Motifs | Terminal LacNAc type2, Nglycan complex, Trimannosylcore, Chitobiose, Internal LacNAc type2 |
| Termini | Neu5Ac(a2-3), Gal(b1-4), Fuc(a1-3) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Man: 3, Neu5Ac: 1, Fuc: 1” |
| Composition | “on” |
| Motifs | core fucose, Terminal LacNAc type2, Internal LacNAc type2, Trimannosylcore |
| Termini | Gal(b1-4), Neu5Ac(a2-6), Fuc(a1-6) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Man: 3, Neu5Ac: 1, Fuc: 1” |
| Composition | “on” |
| Motifs | Terminal LacNAc type2, Nglycan complex, Trimannosylcore, Chitobiose, Internal LacNAc type2 |
| Termini | Gal(b1-4), Neu5Ac(a2-6), Fuc(a1-3) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Neu5Ac: 3, Gal: 3, Man: 3, Fuc: 2” |
| Composition | “on” |
| Motifs | Nglycan complex, Internal LacNAc type2, Trimannosylcore |
| Termini | Neu5Ac(a2-6), Fuc(a1-3) |
10 in stock
| Glycan Type | Not Available |
| Components | “GlcNAc: 5, Gal: 3, Fuc: 3, Man: 3, Neu5Ac: 1” |
| Composition | “on” |
| Motifs | core fucose, Terminal LacNAc type2, Internal LacNAc type2, Trimannosylcore |
| Termini | Gal(b1-4), Neu5Ac(a2-6), Fuc(a1-6) |
10 in stock
Catalog No: A10GD-4280
Cas No: 123549-14-4
Properties: Mol Formula: C17H21N2NaO11, Mol Weight: 452.3
IUPAC Name: sodium;(2S,5R)-5-acetamido-4-hydroxy-2-(4-nitrophenoxy)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate
Synonym: sodium, (2S,4S,6R)-5-acetamido-4-hydroxy-2-(4-nitrophenoxy)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate, 2-O-(P-NITROPHENYL)-ALPHA-D-N-ACETYLNEURAMINIC ACID, SODIUM SALT, X HYDRATE
10 in stock
Catalog No: A10GD-4600
1611491-05-4 , Neu5Aca(2-3)Galb(1-4)Glc-b-pNP;
4-Nitrophenyl O-(N-acetyl-a-neuraminosyl)-(2-3)-b-D-galactopyranosyl-(1-4)-b-D-glucopyranoside,
Cas:1611491-05-4
C29H42N2O21 / 754.64
10 in stock
Catalog No: A10GD-4599
Cas No: 501427-92-5
Properties: Mol Formula: C31H45N3O21, Mol Weight: 795.7
IUPAC Name: (2R,4S,5S,6S)-5-acetamido-2-[(2R,3R,4R,5R,6R)-2-[(2R,3R,4S,5R,6R)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Synonym: (2S,4R,5R,6R)-5-acetamido-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid, N0854, DTXSID80659833
10 in stock
Glycodepot serve all your needs in glycoscience from products, services, networking and announcements. Get the best glycoscience products and services to support your research. Shop Now and learn about cutting-edge solutions in glycochemistry, glycobiology, and glyco-analysis!
![Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-04.svg)
![Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-26.svg)
![Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-33.svg)
![Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-6)[Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-22.svg)
![Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-32.svg)
![Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-10.svg)
![Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-31.svg)
![Neu5Ac(a2-6)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[Neu5Ac(a2-6)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-28.svg)
![Neu5Ac(a2-6)Gal(b1-4)[Fuc(a1-6)]GlcNAc(b1-2)Gal(b1-4)[Fuc(a1-6)]GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/N-Glycan-19.svg)
![G74837KH, Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc](https://glycodepot.com/wp-content/uploads/2024/08/G74837KH.svg)
